Cargando…

SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling

Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Selkirk, Ewan, Patel, Rahima, Hoyle, Anna, Lie-a-Ling, Michael, Smith, Duncan, Swift, Joe, Lacaud, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663857/
https://www.ncbi.nlm.nih.gov/pubmed/36387443
http://dx.doi.org/10.1016/j.heliyon.2022.e11362
_version_ 1784830974328045568
author Selkirk, Ewan
Patel, Rahima
Hoyle, Anna
Lie-a-Ling, Michael
Smith, Duncan
Swift, Joe
Lacaud, Georges
author_facet Selkirk, Ewan
Patel, Rahima
Hoyle, Anna
Lie-a-Ling, Michael
Smith, Duncan
Swift, Joe
Lacaud, Georges
author_sort Selkirk, Ewan
collection PubMed
description Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in AML is still limited. Here, using CRISPRi screening, we identified the lncRNA SGOL1-AS1 as an essential regulator of survival in THP-1 AML cells. We demonstrated that SGOL1-AS1 interacts with chromatin-modifying proteins involved in gene repression and that SGOL1-AS1 knockdown is associated with increased heterochromatin formation. We also observed that loss of SGOLl-AS1 results in increased apoptosis and the downregulation of pro-inflammatory genes. In AML patients, high expression of SGOL1-AS1 correlates with both pro-inflammatory gene expression and poor survival. Altogether, our data reveal that SGOL1-AS1 is an essential regulator of cell survival in AML cell lines and a possible regulator of pro-inflammatory signaling in AML patients.
format Online
Article
Text
id pubmed-9663857
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96638572022-11-15 SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling Selkirk, Ewan Patel, Rahima Hoyle, Anna Lie-a-Ling, Michael Smith, Duncan Swift, Joe Lacaud, Georges Heliyon Research Article Epigenetic dysregulation is a key feature of most acute myeloid leukemia (AML). Recently, it has become clear that long noncoding RNAs (lncRNAs) can play a key role in epigenetic regulation, and consequently also dysregulation. Currently, our understanding of the requirements and roles of lncRNAs in AML is still limited. Here, using CRISPRi screening, we identified the lncRNA SGOL1-AS1 as an essential regulator of survival in THP-1 AML cells. We demonstrated that SGOL1-AS1 interacts with chromatin-modifying proteins involved in gene repression and that SGOL1-AS1 knockdown is associated with increased heterochromatin formation. We also observed that loss of SGOLl-AS1 results in increased apoptosis and the downregulation of pro-inflammatory genes. In AML patients, high expression of SGOL1-AS1 correlates with both pro-inflammatory gene expression and poor survival. Altogether, our data reveal that SGOL1-AS1 is an essential regulator of cell survival in AML cell lines and a possible regulator of pro-inflammatory signaling in AML patients. Elsevier 2022-11-05 /pmc/articles/PMC9663857/ /pubmed/36387443 http://dx.doi.org/10.1016/j.heliyon.2022.e11362 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
Selkirk, Ewan
Patel, Rahima
Hoyle, Anna
Lie-a-Ling, Michael
Smith, Duncan
Swift, Joe
Lacaud, Georges
SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title_full SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title_fullStr SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title_full_unstemmed SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title_short SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
title_sort sgol1-as1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663857/
https://www.ncbi.nlm.nih.gov/pubmed/36387443
http://dx.doi.org/10.1016/j.heliyon.2022.e11362
work_keys_str_mv AT selkirkewan sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT patelrahima sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT hoyleanna sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT liealingmichael sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT smithduncan sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT swiftjoe sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling
AT lacaudgeorges sgol1as1enhancescellsurvivalinacutemyeloidleukemiabymaintainingproinflammatorysignaling